The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksHigh Impact•8 April 2026•

1 min read

Intel Secures $25 Billion 'Terafab' Deal from Elon Musk to Boost Foundry Business

A large Intel CPU is centered on an orange background with manufacturing equipment, a worker, and upward financial arrows showing +4.85%.

Key Facts

1Intel (INTC) is reportedly securing a $25 billion "Terafab" project from Elon Musk, significantly boosting its foundry ambitions.

Version History

5 additional sources confirmed this story

Intel (INTC) is reportedly securing a massive $25 billion "Terafab" project from Elon Musk, marking a significant milestone for its foundry ambitions. The deal is accompanied by a public endorsement from Musk for Intel's AI foundry services, providing critical validation for the company's strategic pivot. This partnership is a key component of Intel's IDM 2.0 strategy as it aims to challenge TSMC's dominance in the semiconductor manufacturing sector. Furthermore, Intel is in advanced negotiations with Google (GOOGL) and Amazon (AMZN) to provide advanced packaging services for their custom AI chips. Securing high-profile clients like Musk, Google, and Amazon positions Intel as a formidable player in the custom silicon market. Market analysts view these developments as a major catalyst for Intel's long-term growth and competitive standing in the global AI landscape.